The US FDA’s proposed rule on Generic Drug Labeling: Explained
The wait is over. In a recent announcement, the US FDA has asserted that the proposed rule of labeling pertaining to generic drugs will be released in July 2016. The much-anticipated rule is expected to ensure that utmost importance would be given to the patient safety while securing the rights of generic drug manufacturers. Before mulling over how the proposed rule would affect the generic manufacturers’ dependency, let us try getting some facts about the patient safety and the labeling status-quo.